Search results
Results From The WOW.Com Content Network
The collapse of the deal is the latest example of how the pharmaceutical industry is battling the US government on a number of fronts, including the White House's move to license drugs that were ...
Current Trends in Biotechnology and Pharmacy is an international quarterly research journal dedicated to pharmaceutical and biotechnology research. The journal is ...
Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. [ 1 ] [ 2 ] It is a sub-discipline of health economics . A pharmacoeconomic study evaluates the cost (expressed in monetary terms) and effects (expressed in terms of monetary value, efficacy or enhanced quality of ...
If the trend can be assumed to be linear, trend analysis can be undertaken within a formal regression analysis, as described in Trend estimation. If the trends have other shapes than linear, trend testing can be done by non-parametric methods, e.g. Mann-Kendall test, which is a version of Kendall rank correlation coefficient.
Pharmaceutical statistics is the application of statistics to matters concerning the pharmaceutical industry. This can be from issues of design of experiments, to analysis of drug trials, to issues of commercialization of a medicine. [1] There are many professional bodies concerned with this field including:
The industry's various subdivisions include distinct areas, such as manufacturing biologics or total synthesis. The industry is subject to a variety of laws and regulations that govern the patenting, efficacy testing, safety evaluation, and marketing of these drugs. The global pharmaceutical market produced treatments worth a total of $1,228.45 ...
The drug pipeline is also sometimes restricted to a particular drug class or extended to mean the process of discovering drugs (the research and development pipeline). [3] The R&D pipeline involves various phases that can broadly be grouped in 4 stages: discovery, pre-clinical, clinical trials and marketing (or post-approval).
This trend is seen all across the healthcare industry, as the price of drugs increase so do the profits of the largest drug companies. Researchers in JAMA found that between 2000 and 2018, 35 of the largest drug companies in the United States received a combined revenue of $11.5 trillion with a gross profit of $8.6 trillion. [69]